Attached files
| file | filename |
|---|---|
| EX-10.25 - THIRD AMENDMENT TO THE SERVICES CONVERTIBLE PROMISSORY NOTE, DATED AS OF NOVEMBE - Virpax Pharmaceuticals, Inc. | fs12020a2ex10-25_virpax.htm |
| EX-10.22 - SERVICE PROVIDER CONVERTIBLE NOTE PURCHASE AGREEMENT, DATED AUGUST 29, 2019, BET - Virpax Pharmaceuticals, Inc. | fs12020a2ex10-22_virpax.htm |
| S-1/A - REGISTRATION STATEMENT - Virpax Pharmaceuticals, Inc. | fs12020a2_virpaxpharma.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the inclusion in this Registration Statement of Virpax Pharmaceuticals, Inc. on Form S-1/A to be filed on or about December 15, 2020 of our report dated August 10, 2020, except with respect to Note 13, as to which the date is November 19, 2020, on our audits of the financial statements as of December 31, 2019 and 2018 and for each of the years then ended. Our report includes an explanatory paragraph about the existence of substantial doubt concerning the Company’s ability to continue as a going concern. We also consent to the reference to our firm under the caption “Experts” in this Registration Statement.
/s/ EisnerAmper LLP
EISNERAMPER LLP
Philadelphia, Pennsylvania
December 15, 2020